Advertisement

Percutaneous Renal Cryoablation

Reference work entry

Abstract

Percutaneous cryoablation is an evolving method of definitive renal mass treatment. With growing experience showing durability of treatment, cryoablation is a reasonable treatment option for an expanding patient population. In addition, large tumors may be treated using multiple cryoprobes. Patients may be treated under IV sedation, although general anesthesia may be more appropriate, particularly for larger tumors or technically complicated cases. Follow-up imaging is typically performed several times in the first 12 months following ablation and then every 6–12 months thereafter, depending on the tumor biology and other clinical indications. Outcomes following ablation have shown short- and midterm local control rates of about 95 %. Major complications are rare, occurring in about 5–7 % of patients.

Keywords

Renal Cell Carcinoma Renal Mass Radio Frequency Ablation Ureteral Injury Papillary Renal Cell Carcinoma 
These keywords were added by machine and not by the authors. This process is experimental and the keywords may be updated as the learning algorithm improves.

References

  1. 1.
    Uchida M, et al. Percutaneous cryosurgery for renal tumours. Br J Urol. 1995;75(2):132–6. discussion 136–7.CrossRefPubMedGoogle Scholar
  2. 2.
    Magrill D, et al. Laparoscopy extirpative renal surgery in the octogenarian population. J Endourol. 2009;23(9):1499–502.CrossRefPubMedGoogle Scholar
  3. 3.
    Atwell TD, et al. Percutaneous renal cryoablation: experience treating 115 tumors. J Urol. 2008;179(6):2136–40. discussion 2140–1.CrossRefPubMedGoogle Scholar
  4. 4.
    Gupta A, et al. Computerized tomography guided percutaneous renal cryoablation with the patient under conscious sedation: initial clinical experience. J Urol. 2006;175(2):447–52. discussion 452–3.CrossRefPubMedGoogle Scholar
  5. 5.
    Littrup PJ, et al. CT-guided percutaneous cryotherapy of renal masses. J Vasc Interv Radiol. 2007;18(3):383–92.CrossRefPubMedGoogle Scholar
  6. 6.
    Silverman SG, et al. Renal tumors: MR imaging-guided percutaneous cryotherapy–initial experience in 23 patients. Radiology. 2005;236(2):716–24.CrossRefPubMedGoogle Scholar
  7. 7.
    Johnson A, et al. Feasibility and outcomes of repeat partial nephrectomy. J Urol. 2008;180(1):89–93. discussion 93.CrossRefPubMedPubMedCentralGoogle Scholar
  8. 8.
    Atwell TD, et al. Percutaneous cryoablation of large renal masses: technical feasibility and short-term outcome. AJR Am J Roentgenol. 2007;188(5):1195–200.CrossRefPubMedGoogle Scholar
  9. 9.
    Littrup PJ, et al. Lethal isotherms of cryoablation in a phantom study: effects of heat load, probe size, and number. J Vasc Interv Radiol. 2009;20(10):1343–51.CrossRefPubMedPubMedCentralGoogle Scholar
  10. 10.
    Bagley DH, et al. Cryosurgery of the ureter in dogs. Invest Urol. 1976;14(3):241–5.PubMedGoogle Scholar
  11. 11.
    Atwell TD, et al. Malignant hypertension during cryoablation of an adrenal gland tumor. J Vasc Interv Radiol. 2006;17(3):573–5.CrossRefPubMedGoogle Scholar
  12. 12.
    Bodily KD, et al. Hydrodisplacement in the percutaneous cryoablation of 50 renal tumors. AJR Am J Roentgenol. 2010;194(3):779–83.CrossRefPubMedGoogle Scholar
  13. 13.
    Froemming A, et al. Probe retraction during renal tumor cryoablation: a technique to minimize direct ureteral injury. J Vasc Interv Radiol. 2010;21(1):148–51.CrossRefPubMedGoogle Scholar
  14. 14.
    Tuncali K, et al. MRI-guided percutaneous cryoablation of renal tumors: use of external manual displacement of adjacent bowel loops. Eur J Radiol. 2006;59(2):198–202.CrossRefPubMedGoogle Scholar
  15. 15.
    Wah TM, et al. Radiofrequency ablation of a central renal tumor: protection of the collecting system with a retrograde cold dextrose pyeloperfusion technique. J Vasc Interv Radiol. 2005;16(11):1551–5.CrossRefPubMedGoogle Scholar
  16. 16.
    Gervais DA, et al. Radiofrequency ablation of renal cell carcinoma: part 1, Indications, results, and role in patient management over a 6-year period and ablation of 100 tumors. AJR Am J Roentgenol. 2005;185(1):64–71.CrossRefPubMedGoogle Scholar
  17. 17.
    Varkarakis IM, et al. Percutaneous radio frequency ablation of renal masses: results at a 2-year mean followup. J Urol. 2005;174(2):456–60. discussion 460.CrossRefPubMedGoogle Scholar
  18. 18.
    Warlick CA, et al. Clinical sequelae of radiographic iceball involvement of collecting system during computed tomography-guided percutaneous renal tumor cryoablation. Urology. 2006;67(5):918–22.CrossRefPubMedGoogle Scholar
  19. 19.
    Dechet CB, et al. Prospective analysis of intraoperative frozen needle biopsy of solid renal masses in adults. J Urol. 1999;162(4):1282–4. discussion 1284–5.CrossRefPubMedGoogle Scholar
  20. 20.
    Dechet CB, et al. Prospective analysis of computerized tomography and needle biopsy with permanent sectioning to determine the nature of solid renal masses in adults. J Urol. 2003;169(1):71–4.CrossRefPubMedGoogle Scholar
  21. 21.
    Wunderlich H, et al. The accuracy of 250 fine needle biopsies of renal tumors. J Urol. 2005;174(1):44–6.CrossRefPubMedGoogle Scholar
  22. 22.
    Heilbrun ME, et al. CT-guided biopsy for the diagnosis of renal tumors before treatment with percutaneous ablation. AJR Am J Roentgenol. 2007;188(6):1500–5.CrossRefPubMedGoogle Scholar
  23. 23.
    Frank I, et al. Solid renal tumors: an analysis of pathological features related to tumor size. J Urol. 2003;170(6 Pt 1):2217–20.CrossRefPubMedGoogle Scholar
  24. 24.
    Thompson RH, et al. Tumor size is associated with malignant potential in renal cell carcinoma cases. J Urol. 2009;181(5):2033–6.CrossRefPubMedPubMedCentralGoogle Scholar
  25. 25.
    Silverman SG, et al. Renal masses in the adult patient: the role of percutaneous biopsy. Radiology. 2006;240(1):6–22.CrossRefPubMedGoogle Scholar
  26. 26.
    Beland MD, et al. Diagnostic yield of 58 consecutive imaging-guided biopsies of solid renal masses: should we biopsy all that are indeterminate? AJR Am J Roentgenol. 2007;188(3):792–7.CrossRefPubMedGoogle Scholar
  27. 27.
    Woodrum DA, et al. Role of intraarterial embolization before cryoablation of large renal tumors: a pilot study. J Vasc Interv Radiol. 2010;21(6):930–6.CrossRefPubMedGoogle Scholar
  28. 28.
    Allaf ME, et al. Pain control requirements for percutaneous ablation of renal tumors: cryoablation versus radiofrequency ablation–initial observations. Radiology. 2005;237(1):366–70.CrossRefPubMedGoogle Scholar
  29. 29.
    Gupta A, et al. General anesthesia and contrast-enhanced computed tomography to optimize renal percutaneous radiofrequency ablation: multi-institutional intermediate-term results. J Endourol. 2009;23(7):1099–105.CrossRefPubMedGoogle Scholar
  30. 30.
    Woolley ML, et al. Effect of freezing parameters (freeze cycle and thaw process) on tissue destruction following renal cryoablation. J Endourol. 2002;16(7):519–22.CrossRefPubMedGoogle Scholar
  31. 31.
    Hoffmann NE, Bischof JC. The cryobiology of cryosurgical injury. Urology. 2002;60(2 Suppl 1):40–9.CrossRefPubMedGoogle Scholar
  32. 32.
    Saliken JC, McKinnon JG, Gray R. CT for monitoring cryotherapy. AJR Am J Roentgenol. 1996;166(4):853–5.CrossRefPubMedGoogle Scholar
  33. 33.
    Chosy SG, et al. Monitoring renal cryosurgery: predictors of tissue necrosis in swine. J Urol. 1998;159(4):1370–4.CrossRefPubMedGoogle Scholar
  34. 34.
    Campbell SC, et al. Renal cryosurgery: experimental evaluation of treatment parameters. Urology. 1998;52(1):29–33. discussion 33–4.CrossRefPubMedGoogle Scholar
  35. 35.
    Goldberg SN, et al. Image-guided tumor ablation: standardization of terminology and reporting criteria. Radiology. 2005;235(3):728–39.CrossRefPubMedPubMedCentralGoogle Scholar
  36. 36.
    Goldberg SN, et al. Image-guided tumor ablation: proposal for standardization of terms and reporting criteria. Radiology. 2003;228(2):335–45.CrossRefPubMedGoogle Scholar
  37. 37.
    Matin SF, et al. Residual and recurrent disease following renal energy ablative therapy: a multi-institutional study. J Urol. 2006;176(5):1973–7.CrossRefPubMedGoogle Scholar
  38. 38.
    Campbell SC, et al. Guideline for management of the clinical T1 renal mass. J Urol. 2009;182(4):1271–9.CrossRefPubMedGoogle Scholar
  39. 39.
    Chin AI, et al. Surveillance strategies for renal cell carcinoma patients following nephrectomy. Rev Urol. 2006;8(1):1–7.PubMedPubMedCentralGoogle Scholar
  40. 40.
    Porter CA, et al. MRI after technically successful renal cryoablation: early contrast enhancement as a common finding. AJR Am J Roentgenol. 2010;194(3):790–3.CrossRefPubMedGoogle Scholar
  41. 41.
    Shingleton WB, Sewell Jr PE. Percutaneous renal tumor cryoablation with magnetic resonance imaging guidance. J Urol. 2001;165(3):773–6.CrossRefPubMedGoogle Scholar
  42. 42.
    Bandi G, et al. Cryoablation of small renal masses: assessment of the outcome at one institution. BJU Int. 2007;100(4):798–801.CrossRefPubMedGoogle Scholar
  43. 43.
    Rodriguez R, et al. Prospective analysis of the safetyand efficacy of percutaneous cryoablation for pT1NxMx biopsy-proven renal cell carcinoma. Cardiovasc Intervent Radiol. 2011;34(3):573–8.CrossRefPubMedGoogle Scholar
  44. 44.
    Atwell TD, et al. Percutaneous renal cryoablation: Local control at mean 26 months of followup. J Urol. 2010;184(4):1291–5.CrossRefPubMedGoogle Scholar
  45. 45.
    Schmit GD, et al. Percutaneous cryoablation of renal masses > or=3 cm: efficacy and safety in treatment of 108 patients. J Endourol. 2010;24(8):1255–62.CrossRefPubMedGoogle Scholar
  46. 46.
    Davol PE, Fulmer BR, Rukstalis DB. Long-term results of cryoablation for renal cancer and complex renal masses. Urology. 2006;68(1 Suppl):2–6.CrossRefPubMedGoogle Scholar
  47. 47.
    Gill IS, et al. Renal cryoablation: outcome at 3 years. J Urol. 2005;173(6):1903–7.CrossRefPubMedGoogle Scholar
  48. 48.
    Sutor AH, Bowie EJ, Owen Jr CA. Effect of temperature on hemostasis: a cold-tolerance test. Blut. 1971;22(1):27–34.CrossRefPubMedGoogle Scholar

Copyright information

© Springer Science+Business Media New York 2013

Authors and Affiliations

  1. 1.Department of Diagnostic RadiologyMayo ClinicRochesterUSA

Personalised recommendations